{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T09:47:01Z","timestamp":1791798421044,"version":"4.3.4"},"reference-count":63,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82304508"],"award-info":[{"award-number":["82304508"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82204916"],"award-info":[{"award-number":["82204916"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005847","name":"Health and Medical Research Fund","doi-asserted-by":"publisher","award":["15162961"],"award-info":[{"award-number":["15162961"]}],"id":[{"id":"10.13039\/501100005847","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005847","name":"Health and Medical Research Fund","doi-asserted-by":"publisher","award":["21222151"],"award-info":[{"award-number":["21222151"]}],"id":[{"id":"10.13039\/501100005847","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005847","name":"Health and Medical Research Fund","doi-asserted-by":"publisher","award":["19201591"],"award-info":[{"award-number":["19201591"]}],"id":[{"id":"10.13039\/501100005847","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100013291","name":"Tongji Medical College, Huazhong University of Science and Technology","doi-asserted-by":"publisher","award":["2022xhyn088"],"award-info":[{"award-number":["2022xhyn088"]}],"id":[{"id":"10.13039\/501100013291","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","award":["2023YFF1205000"],"award-info":[{"award-number":["2023YFF1205000"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010428","name":"Innovation and Technology Fund","doi-asserted-by":"publisher","award":["PRP\/028\/22FX"],"award-info":[{"award-number":["PRP\/028\/22FX"]}],"id":[{"id":"10.13039\/501100010428","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010428","name":"Innovation and Technology Fund","doi-asserted-by":"publisher","award":["PRP\/029\/24FX"],"award-info":[{"award-number":["PRP\/029\/24FX"]}],"id":[{"id":"10.13039\/501100010428","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Phytomedicine"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1016\/j.phymed.2026.158854","type":"journal-article","created":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T14:18:29Z","timestamp":1791123509000},"page":"158854","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Berberine increases the sensitivity of sorafenib in human hepatocellular carcinoma via inducing HIF-1\u03b1-mediated energy crisis"],"prefix":"10.1016","volume":"162","author":[{"given":"Wei","family":"Guo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zixin","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yau-Tuen","family":"Chan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheng","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hor-Yue","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wanyu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ning","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yibin","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.phymed.2026.158854_bib0001","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1158\/1078-0432.CCR-24-3296","article-title":"Mitochondria targeting of oxidative phosphorylation inhibitors to alleviate hypoxia and enhance anticancer treatment efficacy","volume":"31","author":"Beerkens","year":"2025","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.phymed.2026.158854_bib0002","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1186\/s12951-021-00979-1","article-title":"Improving the ameliorative effects of Berberine and curcumin combination via dextran-coated Bilosomes on non-alcohol fatty liver disease in mice","volume":"19","author":"Chen","year":"2021","journal-title":"J. Nanobiotechnology."},{"key":"10.1016\/j.phymed.2026.158854_bib0003","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1038\/s41419-024-07089-4","article-title":"Hypoxia-induced DTL promotes the proliferation, metastasis, and sorafenib resistance of hepatocellular carcinoma through ubiquitin-mediated degradation of SLTM and subsequent Notch pathway activation","volume":"15","author":"Chen","year":"2024","journal-title":"Cell Death. Dis."},{"key":"10.1016\/j.phymed.2026.158854_bib0004","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1038\/s41467-017-02733-4","article-title":"Hexokinase-2 depletion inhibits glycolysis and induces oxidative phosphorylation in hepatocellular carcinoma and sensitizes to metformin","volume":"9","author":"Dewaal","year":"2018","journal-title":"Nat. Commun."},{"key":"10.1016\/j.phymed.2026.158854_bib0005","doi-asserted-by":"crossref","first-page":"169","DOI":"10.2478\/jtim-2023-0091","article-title":"Adrenomedullin induces cisplatin chemoresistance in ovarian cancer through reprogramming of glucose metabolism","volume":"11","author":"Dou","year":"2023","journal-title":"J. Transl. Int. Med."},{"key":"10.1016\/j.phymed.2026.158854_bib0006","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1186\/s13046-019-1194-z","article-title":"PKM2 is the target of proanthocyanidin B2 during the inhibition of hepatocellular carcinoma","volume":"38","author":"Feng","year":"2019","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"10.1016\/j.phymed.2026.158854_bib0007","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2024.216823","article-title":"Hypoxia-associated autophagy flux dysregulation in human cancers","volume":"590","author":"Fu","year":"2024","journal-title":"Cancer Lett."},{"key":"10.1016\/j.phymed.2026.158854_bib0008","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1101\/gr.197566.115","article-title":"nanoCAGE reveals 5\u2032 UTR features that define specific modes of translation of functionally related MTOR-sensitive mRNAs","volume":"26","author":"Gandin","year":"2016","journal-title":"Genome Res."},{"key":"10.1016\/j.phymed.2026.158854_bib0009","doi-asserted-by":"crossref","first-page":"6797","DOI":"10.1111\/jcmm.14560","article-title":"Berberine attenuates XRCC1-mediated base excision repair and sensitizes breast cancer cells to the chemotherapeutic drugs","volume":"23","author":"Gao","year":"2019","journal-title":"J. Cell Mol. Med."},{"key":"10.1016\/j.phymed.2026.158854_bib0010","first-page":"12","article-title":"Targeting cancer metabolism to resensitize chemotherapy: potential development of cancer chemosensitizers from traditional Chinese Medicines","author":"Guo","year":"2020","journal-title":"Cancers. (Basel)"},{"key":"10.1016\/j.phymed.2026.158854_bib0011","first-page":"12","article-title":"Glutamic-pyruvic transaminase 1 facilitates alternative fuels for hepatocellular carcinoma growth-a small molecule inhibitor, Berberine","author":"Guo","year":"2020","journal-title":"Cancers. (Basel)"},{"key":"10.1016\/j.phymed.2026.158854_bib0012","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1186\/s43556-024-00229-4","article-title":"Tumor energy metabolism: implications for therapeutic targets","volume":"5","author":"Hu","year":"2024","journal-title":"Mol. Biomed."},{"key":"10.1016\/j.phymed.2026.158854_bib0013","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1016\/j.jpba.2007.03.022","article-title":"Determination of berberine in human plasma by liquid chromatography-electrospray ionization-mass spectrometry","volume":"44","author":"Hua","year":"2007","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.phymed.2026.158854_bib0014","doi-asserted-by":"crossref","first-page":"2990","DOI":"10.1097\/JS9.0000000000002294","article-title":"Advancements in elucidating the mechanisms of Sorafenib resistance in hepatocellular carcinoma","volume":"111","author":"Huang","year":"2025","journal-title":"Int. J. Surg."},{"key":"10.1016\/j.phymed.2026.158854_bib0015","first-page":"1525","article-title":"Berberine, a natural plant alkaloid, synergistically sensitizes human liver cancer cells to sorafenib","volume":"40","author":"Huang","year":"2018","journal-title":"Oncol. Rep."},{"key":"10.1016\/j.phymed.2026.158854_bib0016","article-title":"Phosphofructokinase-1 in Cancer: a promising target for diagnosis and therapy","author":"Ishaq","year":"2024","journal-title":"Recent. Pat. AntiCancer Drug Discov."},{"key":"10.1016\/j.phymed.2026.158854_bib0017","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2025.217472","article-title":"Drug resistance in TKI therapy for hepatocellular carcinoma: mechanisms and strategies","volume":"613","author":"Jiang","year":"2025","journal-title":"Cancer Lett."},{"key":"10.1016\/j.phymed.2026.158854_bib0018","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.ejphar.2016.11.037","article-title":"Berberine enhances the AMPK activation and autophagy and mitigates high glucose-induced apoptosis of mouse podocytes","volume":"794","author":"Jin","year":"2017","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.phymed.2026.158854_bib0019","doi-asserted-by":"crossref","DOI":"10.1016\/j.drup.2024.101054","article-title":"Inhibition of SIRT7 overcomes sorafenib acquired resistance by suppressing ERK1\/2 phosphorylation via the DDX3X-mediated NLRP3 inflammasome in hepatocellular carcinoma","volume":"73","author":"Kim","year":"2024","journal-title":"Drug Resist. Updat."},{"key":"10.1016\/j.phymed.2026.158854_bib0020","article-title":"Engineered prebiotic microcapsules Co-Encapsulating berberine and curcumin Elicit multi-synergistic therapy for ulcerative colitis","volume":"37","author":"Li","year":"2026","journal-title":"Mater. Today Bio"},{"key":"10.1016\/j.phymed.2026.158854_bib0021","article-title":"ASPH dysregulates cell death and induces chemoresistance in hepatocellular carcinoma","volume":"611","author":"Li","year":"2024","journal-title":"Cancer Lett."},{"key":"10.1016\/j.phymed.2026.158854_bib0022","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2025.178211","article-title":"Berberine sensitizes liver cancer cells to sorafenib by inducing SETDB1\/NQO1\/p53-dependent ferroptosis and genomic instability","volume":"1007","author":"Li","year":"2025","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.phymed.2026.158854_bib0023","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2024.216761","article-title":"Stratifin promotes the malignant progression of HCC via binding and hyperactivating AKT signaling","volume":"592","author":"Li","year":"2024","journal-title":"Cancer Lett."},{"key":"10.1016\/j.phymed.2026.158854_bib0024","doi-asserted-by":"crossref","first-page":"1518","DOI":"10.1038\/bjc.2017.323","article-title":"Genistein suppresses aerobic glycolysis and induces hepatocellular carcinoma cell death","volume":"117","author":"Li","year":"2017","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.phymed.2026.158854_bib0025","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1038\/sj.bjc.6690710","article-title":"Berberine modulates expression of mdr1 gene product and the responses of digestive track cancer cells to Paclitaxel","volume":"81","author":"Lin","year":"1999","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.phymed.2026.158854_bib0026","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1016\/S0026-895X(24)05644-X","article-title":"Berberine inhibits HIF-1alpha expression via enhanced proteolysis","volume":"66","author":"Lin","year":"2004","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.phymed.2026.158854_bib0027","doi-asserted-by":"crossref","DOI":"10.1038\/cddis.2012.149","article-title":"Translation inhibitors induce cell death by multiple mechanisms and Mcl-1 reduction is only a minor contributor","volume":"3","author":"Lindqvist","year":"2012","journal-title":"Cell Death. Dis."},{"key":"10.1016\/j.phymed.2026.158854_bib0028","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1186\/s12943-024-02165-x","article-title":"Metabolic reprogramming and therapeutic resistance in primary and metastatic breast cancer","volume":"23","author":"Liu","year":"2024","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.phymed.2026.158854_bib0029","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1002\/hep.27859","article-title":"Nuclear factor kappa B-mediated CD47 up-regulation promotes sorafenib resistance and its blockade synergizes the effect of sorafenib in hepatocellular carcinoma in mice","volume":"62","author":"Lo","year":"2015","journal-title":"Hepatology"},{"key":"10.1016\/j.phymed.2026.158854_bib0030","doi-asserted-by":"crossref","first-page":"1893","DOI":"10.1002\/hep.26209","article-title":"A novel interaction of nucleophosmin with BCL2-associated X protein regulating death evasion and drug sensitivity in human hepatoma cells","volume":"57","author":"Lo","year":"2013","journal-title":"Hepatology"},{"key":"10.1016\/j.phymed.2026.158854_bib0031","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/s13046-021-02208-x","article-title":"Epigenetic regulation of ferroptosis via ETS1\/miR-23a-3p\/ACSL4 axis mediates sorafenib resistance in human hepatocellular carcinoma","volume":"41","author":"Lu","year":"2022","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"10.1016\/j.phymed.2026.158854_bib0032","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.jare.2022.10.017","article-title":"Thioredoxin-interacting protein-activated intracellular potassium deprivation mediates the anti-tumour effect of a novel histone acetylation inhibitor HL23, a fangchinoline derivative, in human hepatocellular carcinoma","volume":"51","author":"Lu","year":"2023","journal-title":"J. Adv. Res."},{"key":"10.1016\/j.phymed.2026.158854_bib0033","article-title":"Lactylation-driven IGF2BP3-mediated serine metabolism reprogramming and RNA m6A-modification promotes Lenvatinib resistance in HCC","volume":"11","author":"Lu","year":"2024","journal-title":"Adv. Sci. (Weinh)"},{"key":"10.1016\/j.phymed.2026.158854_bib0034","first-page":"2436","article-title":"Berberine decelerates glucose metabolism via suppression of mTOR\u2011dependent HIF\u20111alpha protein synthesis in colon cancer cells","volume":"39","author":"Mao","year":"2018","journal-title":"Oncol. Rep."},{"key":"10.1016\/j.phymed.2026.158854_bib0035","doi-asserted-by":"crossref","DOI":"10.3390\/nu14010124","article-title":"Absorption kinetics of Berberine and Dihydroberberine and their impact on Glycemia: a randomized, controlled, crossover pilot trial","volume":"14","author":"Moon","year":"2021","journal-title":"Nutrients."},{"key":"10.1016\/j.phymed.2026.158854_bib0036","doi-asserted-by":"crossref","DOI":"10.1016\/j.drup.2024.101114","article-title":"Cancer plasticity in therapy resistance: Mechanisms and novel strategies","volume":"76","author":"Niu","year":"2024","journal-title":"Drug Resist. Updat."},{"key":"10.1016\/j.phymed.2026.158854_bib0037","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2025.217732","article-title":"HNF4A functions as a hepatocellular carcinoma oncogene or tumor suppressor depending upon the AMPK pathway activity status","volume":"623","author":"Qin","year":"2025","journal-title":"Cancer Lett."},{"key":"10.1016\/j.phymed.2026.158854_bib0038","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2025.126177","article-title":"Improving the oral bioavailability of berberine: A crystal engineering approach","volume":"685","author":"Sai Durga Surampudi","year":"2025","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.phymed.2026.158854_bib0039","doi-asserted-by":"crossref","DOI":"10.3390\/cancers11081144","article-title":"Cancer Metabolism and the Evasion of Apoptotic Cell Death","volume":"11","author":"Sharma","year":"2019","journal-title":"Cancers. (Basel)"},{"key":"10.1016\/j.phymed.2026.158854_bib0040","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1038\/bjc.2012.559","article-title":"Activating oxidative phosphorylation by a pyruvate dehydrogenase kinase inhibitor overcomes sorafenib resistance of hepatocellular carcinoma","volume":"108","author":"Shen","year":"2013","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.phymed.2026.158854_bib0041","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1271\/bbb.60441","article-title":"Human MDR1 and MRP1 recognize berberine as their transport substrate","volume":"71","author":"Shitan","year":"2007","journal-title":"Biosci. Biotechnol. Biochem."},{"key":"10.1016\/j.phymed.2026.158854_bib0042","doi-asserted-by":"crossref","DOI":"10.1016\/j.drup.2025.101248","article-title":"Lactylation in cancer progression and drug resistance","volume":"81","author":"Sun","year":"2025","journal-title":"Drug Resist. Updat."},{"key":"10.1016\/j.phymed.2026.158854_bib0043","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1016\/j.bbadis.2014.12.004","article-title":"Berberine suppresses Id-1 expression and inhibits the growth and development of lung metastases in hepatocellular carcinoma","volume":"1852","author":"Tsang","year":"2015","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.phymed.2026.158854_bib0044","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.jconrel.2020.12.007","article-title":"Multivalent rubber-like RNA nanoparticles for targeted co-delivery of paclitaxel and MiRNA to silence the drug efflux transporter and liver cancer drug resistance","volume":"330","author":"Wang","year":"2021","journal-title":"J. Control Release"},{"key":"10.1016\/j.phymed.2026.158854_bib0045","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.jep.2015.10.028","article-title":"Berberine and Coptidis Rhizoma as potential anticancer agents: Recent updates and future perspectives","volume":"176","author":"Wang","year":"2015","journal-title":"J. Ethnopharmacol."},{"key":"10.1016\/j.phymed.2026.158854_bib0046","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1016\/j.bbagrm.2014.05.027","article-title":"Berberine-induced tumor suppressor p53 up-regulation gets involved in the regulatory network of MIR-23a in hepatocellular carcinoma","volume":"1839","author":"Wang","year":"2014","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.phymed.2026.158854_bib0047","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1016\/j.phymed.2008.05.002","article-title":"Enhancement of apoptosis of human hepatocellular carcinoma SMMC-7721 cells through synergy of berberine and evodiamine","volume":"15","author":"Wang","year":"2008","journal-title":"Phytomedicine"},{"key":"10.1016\/j.phymed.2026.158854_bib0048","doi-asserted-by":"crossref","DOI":"10.1016\/j.drup.2025.101229","article-title":"Overcoming cancer therapy resistance: From drug innovation to therapeutics","volume":"81","author":"Wei","year":"2025","journal-title":"Drug Resist. Updat."},{"key":"10.1016\/j.phymed.2026.158854_bib0049","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1186\/s13046-024-02967-3","article-title":"PARD3 drives tumorigenesis through activating Sonic Hedgehog signalling in tumour-initiating cells in liver cancer","volume":"43","author":"Wu","year":"2024","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"10.1016\/j.phymed.2026.158854_bib0050","doi-asserted-by":"crossref","first-page":"1867","DOI":"10.1007\/s00726-023-03345-7","article-title":"Binding of berberine to PEBP1 synergizes with sorafenib to induce the ferroptosis of hepatic stellate cells","volume":"55","author":"Xie","year":"2023","journal-title":"Amino Acids."},{"key":"10.1016\/j.phymed.2026.158854_bib0051","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1186\/s12951-024-02804-x","article-title":"Berberine and magnolol exert cooperative effects on ulcerative colitis in mice by self-assembling into carrier-free nanostructures","volume":"22","author":"Xu","year":"2024","journal-title":"J. Nanobiotechnology."},{"key":"10.1016\/j.phymed.2026.158854_bib0052","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.jsbmb.2018.06.010","article-title":"Combinatorial treatment of Rhizoma Paridis saponins and sorafenib overcomes the intolerance of sorafenib","volume":"183","author":"Yao","year":"2018","journal-title":"J. Steroid. Biochem. Mol. Biol."},{"key":"10.1016\/j.phymed.2026.158854_bib0053","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1186\/s13046-015-0221-y","article-title":"Metabolic reprogramming: the emerging concept and associated therapeutic strategies","volume":"34","author":"Yoshida","year":"2015","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"10.1016\/j.phymed.2026.158854_bib0054","doi-asserted-by":"crossref","DOI":"10.1016\/j.critrevonc.2025.104765","article-title":"Insights into Sorafenib resistance in hepatocellular carcinoma: Mechanisms and therapeutic aspects","volume":"212","author":"Yousef","year":"2025","journal-title":"Crit. Rev. Oncol. Hematol."},{"key":"10.1016\/j.phymed.2026.158854_bib0055","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1097\/HEP.0000000000000572","article-title":"The rapidly evolving landscape of HCC: Selecting the optimal systemic therapy","volume":"81","author":"Zanuso","year":"2025","journal-title":"Hepatology"},{"key":"10.1016\/j.phymed.2026.158854_bib0056","doi-asserted-by":"crossref","first-page":"771","DOI":"10.3350\/cmh.2024.0236","article-title":"UBE2S promotes glycolysis in hepatocellular carcinoma by enhancing E3 enzyme-independent polyubiquitination of VHL","volume":"30","author":"Zhang","year":"2024","journal-title":"Clin. Mol. Hepatol."},{"key":"10.1016\/j.phymed.2026.158854_bib0057","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1080\/01635581.2025.2466233","article-title":"Potentiation of Sorafenib's Action by Berberine via Suppression of the mTOR Signaling Pathway in Human Hepatoma Cells","volume":"77","author":"Zhang","year":"2025","journal-title":"Nutr. Cancer"},{"key":"10.1016\/j.phymed.2026.158854_bib0058","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbcan.2025.189310","article-title":"Sorafenib resistance and therapeutic strategies in hepatocellular carcinoma","volume":"1880","author":"Zhang","year":"2025","journal-title":"Biochim. Biophys. Acta Rev. Cancer"},{"key":"10.1016\/j.phymed.2026.158854_bib0059","doi-asserted-by":"crossref","first-page":"567","DOI":"10.3892\/or.2016.4785","article-title":"Berberine in combination with cisplatin suppresses breast cancer cell growth through induction of DNA breaks and caspase-3-dependent apoptosis","volume":"36","author":"Zhao","year":"2016","journal-title":"Oncol. Rep."},{"key":"10.1016\/j.phymed.2026.158854_bib0060","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2025.157030","article-title":"Multiple target and regulatory pathways of berberine","volume":"146","author":"Zhou","year":"2025","journal-title":"Phytomedicine"},{"key":"10.1016\/j.phymed.2026.158854_bib0061","doi-asserted-by":"crossref","DOI":"10.3390\/cancers11091231","article-title":"Metabolic Abnormalities in Glioblastoma and Metabolic Strategies to Overcome Treatment Resistance","volume":"11","author":"Zhou","year":"2019","journal-title":"Cancers. (Basel)"},{"key":"10.1016\/j.phymed.2026.158854_bib0062","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1038\/s41419-022-05180-2","article-title":"MYBL1 induces transcriptional activation of ANGPT2 to promote tumor angiogenesis and confer sorafenib resistance in human hepatocellular carcinoma","volume":"13","author":"Zhu","year":"2022","journal-title":"Cell Death. Dis."},{"key":"10.1016\/j.phymed.2026.158854_bib0063","doi-asserted-by":"crossref","DOI":"10.1002\/cbdv.202502803","article-title":"Comparative Pharmacokinetics and Tissue Distribution of Berberine From Bile-Processed Coptidis Rhizoma in Type 2 Diabetic Rats","volume":"23","author":"Zhu","year":"2026","journal-title":"Chem. Biodivers."}],"container-title":["Phytomedicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0944711326010834?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0944711326010834?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T09:04:00Z","timestamp":1791795840000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0944711326010834"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,11]]},"references-count":63,"alternative-id":["S0944711326010834"],"URL":"https:\/\/doi.org\/10.1016\/j.phymed.2026.158854","relation":{},"ISSN":["0944-7113"],"issn-type":[{"value":"0944-7113","type":"print"}],"subject":[],"published":{"date-parts":[[2026,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Berberine increases the sensitivity of sorafenib in human hepatocellular carcinoma via inducing HIF-1\u03b1-mediated energy crisis","name":"articletitle","label":"Article Title"},{"value":"Phytomedicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.phymed.2026.158854","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier GmbH. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"158854"}}